Central dopamine D
2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine
/ pharmacology
Animals
Autonomic Pathways
/ drug effects
Benzazepines
/ pharmacology
Blood Glucose
/ genetics
Central Nervous System
/ drug effects
Dopamine D2 Receptor Antagonists
/ pharmacology
Humans
Mice
Mice, Knockout
Quinpirole
/ pharmacology
Receptors, Dopamine D1
/ agonists
Receptors, Dopamine D2
/ agonists
Sulpiride
/ pharmacology
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
18 12 2020
18 12 2020
Historique:
received:
04
08
2020
accepted:
07
12
2020
entrez:
19
12
2020
pubmed:
20
12
2020
medline:
29
4
2021
Statut:
epublish
Résumé
Recent evidence suggests that the central nervous system (CNS) regulates plasma glucose levels, but the underlying mechanism is unclear. The present study investigated the role of dopaminergic function in the CNS in regulation of plasma glucose levels in mice. I.c.v. injection of neither the dopamine D
Identifiants
pubmed: 33339892
doi: 10.1038/s41598-020-79292-0
pii: 10.1038/s41598-020-79292-0
pmc: PMC7749102
doi:
Substances chimiques
Benzazepines
0
Blood Glucose
0
Dopamine D2 Receptor Antagonists
0
Receptors, Dopamine D1
0
Receptors, Dopamine D2
0
SCH 23390
0
Quinpirole
20OP60125T
2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine
67287-49-4
Sulpiride
7MNE9M8287
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
22347Références
Biochem Biophys Res Commun. 2019 Nov 12;519(3):547-552
pubmed: 31537386
Diabetes Obes Metab. 2013 Dec;15(12):1128-35
pubmed: 23782571
Br J Pharmacol Chemother. 1957 Mar;12(1):12-5
pubmed: 13413144
J Pharmacol Exp Ther. 2012 Aug;342(2):541-51
pubmed: 22593095
Br J Pharmacol. 1991 Jul;103(3):1824-8
pubmed: 1718526
Neuroendocrinology. 1999 Mar;69(3):160-6
pubmed: 10087448
Can J Physiol Pharmacol. 1991 Aug;69(8):1178-83
pubmed: 1782599
J Neurosci. 2012 Jan 25;32(4):1311-28
pubmed: 22279216
Mol Endocrinol. 2012 Nov;26(11):1928-40
pubmed: 22918877
Am J Physiol Endocrinol Metab. 2005 Apr;288(4):E715-22
pubmed: 15585594
J Clin Invest. 1973 Sep;52(9):2102-16
pubmed: 4727451
Neuroscience. 2016 Apr 21;320:183-93
pubmed: 26855191
Nat Commun. 2018 Jul 19;9(1):2830
pubmed: 30026565
Nat Commun. 2017 May 04;8:15259
pubmed: 28469281
Cell Metab. 2007 Feb;5(2):91-102
pubmed: 17276352
Annu Rev Nutr. 1999;19:379-406
pubmed: 10448530
Br J Pharmacol. 2003 Aug;139(8):1425-32
pubmed: 12922929
Neuroscience. 2015 Dec 17;311:9-21
pubmed: 26454026
Exp Mol Med. 2016 Mar 11;48:e216
pubmed: 26964832
Rev Diabet Stud. 2007 Fall;4(3):185-94
pubmed: 18084676
Neuropsychopharmacol Rep. 2019 Dec;39(4):289-296
pubmed: 31618533
Diabetologia. 2000 Apr;43(4):393-410
pubmed: 10819232
Neuroendocrinology. 2013;98(3):224-32
pubmed: 24135197
Brain Res. 1991 Apr 19;546(2):235-40
pubmed: 1829974
Anat Rec A Discov Mol Cell Evol Biol. 2004 Sep;280(1):808-20
pubmed: 15382020
Neuroendocrinology. 2012;95(4):332-43
pubmed: 22441304
Am J Physiol Regul Integr Comp Physiol. 2002 Oct;283(4):R905-10
pubmed: 12228060
J Clin Pharm Ther. 1992 Jun;17(3):155-64
pubmed: 1353501
J Biol Chem. 2005 Nov 4;280(44):36824-32
pubmed: 16129680
Diabetes Obes Metab. 2012 Apr;14(4):335-40
pubmed: 22074059
J Comp Neurol. 2001 Mar 19;431(4):405-23
pubmed: 11223811
Brain Res Bull. 1988 Aug;21(2):239-44
pubmed: 3191410
Endocrinology. 2014 Mar;155(3):829-39
pubmed: 24424036
Life Sci. 1982 Mar 15;30(11):913-20
pubmed: 7070201
J Physiol. 1985 Jul;364:105-12
pubmed: 3897517
Diabetes Care. 2000 Aug;23(8):1154-61
pubmed: 10937514
Addict Biol. 2014 Jan;19(1):27-36
pubmed: 22500955
J Clin Psychiatry. 2005 Nov;66(11):1463-7
pubmed: 16420085
Eur J Pharmacol. 2013 Oct 15;718(1-3):376-82
pubmed: 23973646
Neurosci Res. 2007 Jun;58(2):105-12
pubmed: 17298852